Dermelix Biotherapeutics, LLC
11
J Kate Stickles
05/09/2023
04/16/2024
Yes
v
| PlnDue, Subchapter_V, JNTADMN, CLMSAGNT |
Assigned to: Bankruptcy Judge J Kate Stickles Chapter 11 Voluntary Asset |
|
Debtor Dermelix Biotherapeutics, LLC
600 3rd Avenue 19th Floor New York, NY 10016 NEW YORK-NY Tax ID / EIN: 83-2644711 aka Dermelix, LLC |
represented by |
R. Craig Martin
DLA Piper LLP (US) 1201 North Martket Street Suite 2100 Wilmington, DE 19801 302-468-5655 Fax : 302-778-7834 Email: craig.martin@dlapiper.com Matthew Steven Sarna
DLA Piper LLP (US) 1201 N. Market Street Suite 2100 Wilmington, DE 19801 302-468-5659 Fax : 302-397-2336 Email: matthew.sarna@us.dlapiper.com |
U.S. Trustee U.S. Trustee
Office of the United States Trustee J. Caleb Boggs Federal Building 844 King Street, Suite 2207 Lockbox 35 Wilmington, DE 19801 (302)-573-6491 |
| |
Claims Agent Epiq Corporate Restructuring, LLC
www.epiqsystems.com 777 Third Avenue, 12th Floor New York, NY 10017 646-282-2500 |
| Date Filed | # | Docket Text |
|---|---|---|
| 06/05/2023 | 6 | Schedules/Statements filed: , Stmt of Financial Affairs,. Filed by Dermelix Biotherapeutics, LLC. (Sarna, Matthew) (Entered: 06/05/2023) |
| 06/05/2023 | 5 | Schedules/Statements filed: Sch A-B, Sch D, Sch E-F, Sch G, Sch H, , Sum of Assets and Liabilities, Decl Concerning Debtors Schs,. Filed by Dermelix Biotherapeutics, LLC. (Sarna, Matthew) (Entered: 06/05/2023) |
| 05/18/2023 | 4 | Order Authorizing (1) The Joint Administration Of The Debtor's Subchapter V Cases And (II) Granting Related Relief "An Order has been entered in this case directing the proceduralconsolidation and joint administration of the subchapter V cases of Vyera Pharmaceuticals, LLC (1758); Oakrum Pharma, LLC (3999); SevenScore Pharmaceuticals, LLC (2598); Phoenixus AG (1091); Dermelix Biotherapeutics, LLC (4711); and Orpha Labs AG. The Debtors headquarters and the mailing address for the Debtors is 600 3rd Avenue, 19th Floor, New York, NY 10016. The docket in the subchapter V case of Vyera Pharmaceuticals, LLC, Case No. 23-10605, should be consulted for all matters affecting this case. Alternatively, information concerning these jointly administered subchapter V cases may be obtained by visiting the website of the Debtors claims and noticing agent: http://dm.epiq11.com/Vyera." Signed on 5/18/2023 (AJL) (Entered: 05/18/2023) |
| 05/18/2023 | 3 | Motion for Joint Administration Filed by Dermelix Biotherapeutics, LLC, Oakrum Pharma, LLC, Orpha Labs AG, Phoenixus AG, SevenScore Pharmaceuticals, LLC. (Sarna, Matthew) (Entered: 05/18/2023) |
| 05/10/2023 | Judge J Kate Stickles added to case (SJS) (Entered: 05/10/2023) | |
| 05/09/2023 | 2 | Receipt of filing fee for Voluntary Petition (Chapter 11)( 23-10610) [misc,volp11a] (1738.00). Receipt Number A11086414, amount $1738.00. (U.S. Treasury) (Entered: 05/09/2023) |
| 05/09/2023 | 1 | Chapter 11 Voluntary Petition . Fee Amount $1738. Filed by Dermelix Biotherapeutics, LLC. Chapter 11 Plan Small Business Subchapter V Due by 08/7/2023. (Martin, R.) (Entered: 05/09/2023) |